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Spermatogenesis in the mammalian testis results in the daily production of millions of 
spermatozoa. This developmental process is founded upon the actions of a small 
population of spermatogonial stem cells (SSCs). As SSCs divide, their progeny must 
either remain an SSC to maintain the stem cell pool (self-renewal) or become an 
undifferentiated progenitor spermatogonium that proliferates prior to differentiating in 
response to retinoic acid (RA) and entering meiosis. Our laboratory is focused on 
understanding the mechanisms that regulate these fate decisions as well as defining 
the changes that occur downstream of RA that prepare spermatogonia for entry into 
meiosis. Currently, researchers have been unable to readily isolate pure populations of 
spermatogonia in the developing or adult testis. To address this, I have examined 
multiple transgenic mouse models to identify those with germ cell-specific expression of 
fluorescent reporter genes that will enable us to isolate spermatogonia using 
fluorescence-activated cell sorting (FACS). The results in this thesis describe these 
 
 
efforts, and document the identification of an excellent mouse model for future studies 
in our laboratory to understand the mechanisms underlying spermatogonial 
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CHAPTER 1: Introduction 
 
General introduction to spermatogenesis – mitosis, meiosis, spermiogenesis 
 The survival of all living organism depends on reproduction. In diploid organisms, 
sexual reproduction relies on actions of the gametes, the sperm and the egg. These 
distinct gametes must find each other, recognize that they belong to the same species, 
and then fuse their haploid genomes to create a new diploid organism.  Gametogenesis 
in females, termed oogenesis, is significantly different than spermatogenesis in males. 
The resulting gametes are also distinct. Eggs are generally larger, immotile, and 
possess abundant cytoplasmic material necessary for early embryonic development, 
sperm are compact, motile, carry minimal cytoplasm, and are produced in large 
quantities. The continuation of life on Earth for sexually-reproducing species is 
dependent on spermatogenesis and oogenesis.  
Spermatogenesis is a complex and highly efficient process producing millions of 
terminally differentiated and specialized sperm every day in males. Male germ cells 
must pass through multiple differentiation steps in order to become sperm [1], and these 
steps can be used to divide the process into three main developmental phases. The 
first, or mitotic phase, involves spermatogonia. Male germline stem cells (also termed 
spermatogonial stem cells, or SSCs) proliferate to amplify their population as well as to 
produce committed progenitor spermatogonia that undergo multiple mitotic divisions 
before entering the second phase. The second phase is meiosis, and involves 
spermatocytes. During meiosis, DNA is replicated without division and the resulting 
chromosomes synapse in pairs and recombine their DNA before 2 subsequent 
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reduction divisions produce haploid spermatids. In the third phase of spermiogenesis, 
spermatids undergo a morphogenetic transformation to become sperm. Detailed 
aspects of these processes will be discussed in greater detail later in the introduction.  
 
Formation of the male germline and prenatal development 
The germline is set aside early during embryonic development in mammals. This 
process has been best described in the mouse, although evidence in humans reveals 
that the processes are remarkably similar. A small number of cells become committed 
to the germ cell lineage and are termed primordial germ cells (PGCs). PGCs can be first 
identified as a cluster of approximately 40 alkaline phosphatase positive cells around 
embryonic day (E)7.25 [2]. Over the next few days of development, PGCs undertake a 
long voyage to eventually take up residence in the developing gonads. They first 
migrate to the developing hindgut endoderm by E7.75 [3], then into the mesentery by 
E9.5 [4], and then arrive at the genital ridges (future gonads) around E10.5 [3, 5]. Sex 
determination occurs around E10.5, and subsequently the PGCs in the testis become 
prospermatogonia (also known as gonocytes). Prospermatogonia proliferate until 
approximately E15.5 and then exit the cell cycle and enter a prolonged period of mitotic 
arrest in G0 [6, 7]. This quiescent period persists until after birth when, in response to an 
unknown signal(s), prospermatogonia reenter the cell cycle to become spermatogonia 
at P3-P4 [8]; this event defines the beginning of spermatogenesis.  
 
The initiation of spermatogenesis – postnatal development  
This initial cohort of spermatogonia in the mouse testis is heterogenous, and 
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contains SSCs which will undergo self-renewal as well as proliferating and 
differentiating spermatogonia. SSCs undergo asymmetric cell divisions and progeny 
either remain an SSC to maintain their population or become undifferentiated 
spermatogonia that will eventually become differentiating spermatogonia. The first 
differentiating spermatogonia then proceed through the 3 stages of spermatogenesis 
(mitosis, meiosis, and spermiogenesis) in the mouse without temporal interruption. 
Once differentiated, type A spermatogonia undergo 6 divisions before entering meiosis 
and becoming the first preleptotene spermatocytes at P8. At the completion of meiosis, 
haploid and round spermatids undergo dramatic morphological and chromatin changes 
during spermiogenesis prior to being released into the lumina of seminiferous tubules as 
testicular sperm. These first testicular sperm are produced as early as ~P35 in mice [9] 
(Figure 1.).  
 
The mitotic divisions - spermatogonia 
The foundation of spermatogenesis throughout the lengthy male reproductive 
lifespan is provided by spermatogonia, which represent a tissue-specific stem cell 
system conceptually similar to those in other body systems (e.g. intestine, skin, 
hematopoiesis). These mitotically-active spermatogonia exist as the aforementioned 3 
main subtypes (stem/SSC, undifferentiated progenitor, and differentiating). SSCs 
undergo asymmetric cell divisions, and progeny either become another stem cell (self-
renewal) or a transit-amplifying undifferentiated progenitor spermatogonium [10] that 
proliferates before committing to differentiate in response to retinoic acid (RA) [11]. 
Maintaining the delicate balance between self-renewal and differentiation is critical to 
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sustained production of functional spermatozoa throughout the male reproductive 
lifespan. Impaired SSC self-renewal or enhanced differentiation result in dramatic 
reduction or total loss of the germline, resulting in infertility. Improper maintenance of 
the spermatogonial populations has also been proposed to cause carcinoma in situ 
(CIS), the precursor lesion to testicular germ cell tumors (TGCTs) [12].  
Spermatogonial fates are established as early as P3-4 in the mouse, with Aundiff 
(SSC and progenitor) and Adiff (differentiating) spermatogonia expressing specific 
mRNAs and protein markers [13]. Many of these markers have been directly linked to 
spermatogonial fate based on analysis of mouse models in which these genes have 
been deleted; the relative role of specific gene products in spermatogonial development 
can be assess by analyzing reproductive phenotypes and by performing heterologous 
transplantation assays [13, 14]. A large number of protein markers have been identified 
that are expressed in Aundiff spermatogonia, including GFRA1 [15, 16], RET [17], ID4 [9], 
ZBTB16/PLZF [18], [19], CDH1 [20], and SOX3 [21]. However, few proteins have been 
identified that are upregulated in or only detectable in Adiff spermatogonia; the few that 
are currently known include KIT [22-25], STRA8 [26, 27], SOHLH1, and SOHLH2 [28]. 
The undifferentiated spermatogonial pool is heterogeneous and provides the 
foundation for spermatogenesis. It is clear that the Aundiff spermatogonia contains both 
the SSCs as well as the transit-amplifying spermatogonia that proliferate and are poised 
to differentiate (Ellen Velte, unpublished results). As isolated undifferentiated 
spermatogonia (termed Asingle or As) divide, their progeny can remain connected by an 
intercellular bridge (ICB), and these are termed Apaired or Apr spermatogonia. Further 
divisions grow the length of these ICB-connected chains of spermatogonia, which are 
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now termed Aaligned or Aal spermatogonia [12]. The function of ICBs is not fully 
understood; however, they are evolutionarily well-conserved among species, and large 
enough for passage of macromolecules and even organelles such as mitochondria [29]. 
Studies from Dr. Braun show that X- and Y-linked gene products can be shared among 
adjacent spermatids that are connected by ICBs suggesting that the products of most 
genes may be equally distributed among spermatids [30].  
Evidence derived from rodent studies reveals that the majority of stem cell 
activity resides within the As population. The most widely accepted model depicting the 
dynamics of the SSC and progenitor spermatogonial pool is referred to as the “Asingle 
model”. The first evidence supporting this model came from studying spermatogenesis 
in rats in 1971 [31, 32]. These and multiple reports derived from rodent studies 
suggested that stem cell activity resides exclusively within the isolated Asingle  
population, with appearance of an  Apaired spermatogonia signifying commitment to a 
differentiation pathway. Transplantation studies done later in mice support this model [9, 
33]. However, recent studies show, that while the “Asingle” hypothesis states that all 
SSCs exist as Asingle cells, not all Asingle cells are believed to be SSCs. Based on 
transplantation assays, it has been estimated that only ~10% of the As population 
exhibit stem-cell capacity, or the ability to seed spermatogenesis when transplanted into 
a testis lacking a germline [34].  
Multiple reports have described heterogeneity of a variety of genes and/or 
encoded protein markers among undifferentiated spermatogonia. Several proteins 
(GFRA1, ID4, LIN28, PAX7, ZBTB16/PLZF) show expression patterns that vary among 
Aundiff spermatogonia with different clone length and between different spermatogonial 
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clones of the same length [9, 35-37]. Heterogeneous expression patterns have also 
been reported within individual spermatogonial clones for markers such as GFRA1 or 
NANOS2 [35, 36] suggesting Aundiff exist as multiple dynamic subpopulation. Another 
functional characteristic of neonatal spermatogonia is their ability to respond to RA 
signaling [38]. Our laboratory reported recently that both ZBTB16/PLZF and CDH1 are 
expressed in nearly all spermatogonia from P1 through P7, while markers of Adiff, 
STRA8 and KIT, are only detectable in a subset of spermatogonia at P4, coincident with 
onset of RA signaling. From P10 and further, distinct populations of Aundiff and Adiff 
exhibit a unique pattern of expression of spermatogonial fate markers. This indicates 
either entry into differentiation phase or retention of the SSC phenotype [14]. Taken 
together, the evidence in the literature clearly supports the presence of heterogeneity 
among male germ cells in the neonatal testis.  
Spermatogonial differentiation is a complex process that is initiated by RA, which 
is a bioactive metabolite of vitamin A (retinol) and a key regulator of spermatogenesis. 
Evidence in the literature reveals that the primary source of RA in the developing mouse 
testis is Sertoli cells. The deletion of retinol dehydrogenase (Rdh10), a key enzyme in 
biosynthesis of retinal from retinol [54] in Sertoli cells, resulted in loss of differentiating 
spermatogonia [53]. Literature suggests that RDH10 may be a key enzyme responsible 
for the postnatal testicular RA synthesis. RA signaling is mediated through three RA 
receptors (RARs) that are localized within the nucleus, and involved in both ligand-
dependent activation of target genes [39].  
The current understanding of critical importance of RA in spermatogenesis has 
been acquired from studies employing dietary, genetic, and chemical approaches. The 
 
 7 
effects of dietary depletion of RA has been studied by many laboratories though 
analyzing Vitamin A-Depleted (VAD) testes. VAD mice can be supplemented with RA 
during different time points to reinitiate spermatogenesis, and this approach has 
provided us an extensive collection of gene expression data [40, 41], as well as 
providing an insight of SSCs ability to maintain their “stemness” in low vitamin A 
environment in the adult animal [42].  
Unfortunately, the effects of dietary vitamin A depletion on spermatogenesis has 
only been collected from adult rodents, as complete vitamin A depletion requires several 
weeks to be achieved. In order to investigate the RA action in neonatal testis, animals 
carrying null mutations of the retinoid storage (LRAT) or transport (RBP4) enzymes 
have been developed. The Lrat-null model was used to demonstrate another important 
feature of RA, the role in meiotic initiation during the first round of spermatogenesis. 
Spermatogonia that failed to enter meiosis in this model were arrested in an 
undifferentiated state [43]. The Rbp4-null model also exhibited the same phenotype. 
Collectively, these finding suggest that vitamin A and its metabolites regulate 
spermatogonial differentiation and meiotic initiation. It is clear, however, that much more 
experimental data must be gathered to gain a complete understanding of the role of RA 
in the initiation of meiosis. [41, 44-47].   
Chemical approaches have become common methods to suppress RA levels in 
mice in vivo. This method is based on oral administration of chemical compound Bis-
dichloroacetyl-diamine, also known as BDAD. One specific BDAD, WIN 18,446 (WIN) 
was shown to reversibly block spermatogenesis. Ex vivo studies have shown that WIN 
acts as a blocker of RA production, while in vivo studies demonstrated reduced RA 
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levels, reduced levels of RA responsive genes, and an accumulation of undifferentiated 
spermatogonia [48-50]. This method has been shown to be faster, and safer compare to 
the alternatives described earlier. The manipulations of RA levels has become a 
commonly used procedure in our laboratory and we plan on employing this technique 
on transgenic mouse models described later in the introduction section of this work.  
 Following RA exposure, undifferentiated spermatogonia become type A1, and 
they will undergo five additional divisions to become A2, A3, A4, intermediate (In), and 
type B spermatogonia before finally entering meiosis as preleptotene spermatocytes 
[32, 51]. Therefore, the developmental progression that spermatogonia make towards 
meiosis requires a consistent, albeit perhaps not continuous supply of RA [52].  
 
The SSC Niche 
 The maintenance of the SSC population theoretically relies on a unique niche 
microenvironment within the testis. This niche would be predicted to involve the 
adjacent somatic Sertoli cells, peritubular myoid cells and interstitial vascular cells, 
Leydig cells, and macrophages [55-57].   
Sertoli cells are thought to be among cells that are most involved in the formation 
of the putative niche microenvironment. These somatic cells are positioned alongside 
spermatogonia within the seminiferous epithelium (Fig. 4A), and will eventually support 
all phase of germ cell development.  
These cells are critically important for SSC niche, and this is demonstrated by 
their abundance and direct association with fluctuation in the SSC pool.  
A study published in 2011 by the Oatley laboratory showed that increasing the number 
 
 9 
of Sertoli cells in mouse testes by manipulating thyroid hormone levels increased the 
number of SSCs [58]. 
 Another important function of Sertoli cells is formation of junctional complexes of 
BTB. The BTB divides the seminiferous epithelium into adluminal and basal 
compartments, and provides a functional barrier to prevent passage of biomolecules 
and toxins from the circulatory and lymphatic systems into the adluminal compartment 
[59-61]. This division creates an immune-privileged area for germ cell meiosis and 
spermatid development. The BTB is a critical component that is required for continuous 
spermatogenesis in the adult.  
In addition to tubular Sertoli cells, cells within the interstitial tissue between 
seminiferous cords and tubules also would be predicted to influence the regulation of 
spermatogenesis, perhaps by regulating the SSC niche. The interstitial tissue consists 
of Leydig cells, macrophages, peritubular myoid (PTM) cells, as well as abundant cell 
types associated with vasculature and innervation. It has been shown that 
spermatogenesis is dependent upon hormonal stimuli provided by somatic cells that 
result in a complex pattern of intratesticular signaling pathways [62]. The two main 
hormones responsible for its control are pituitary follicle stimulating hormone (FSH), and 
testosterone, which is produced by the testicular Leydig cells under the influence of 
pituitary luteinizing hormone (LH). The importance of these hormones on 
spermatogenesis has been demonstrated in pioneering works of Greep and Smith in the 
1920s and 1930s [63]. Both hormones play a role in the initiation of spermatogenesis, 
germ cell proliferation, development and differentiation. 
 Another example of critical importance of somatic cells is PTM cells. These 
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squamous smooth muscle cells reside in the interstitium of the fetal testis and migrate to 
surround the exterior of the testis cords in the neonatal testis [64, 65]. Similar to Sertoli 
cells, PTM cells provide structural support to developing germ cells. In recent years it 
has become more apparent that PTM cells are also critical regulators of 
spermatogenesis. For a long time Sertoli cells were considered the only source of 
secreted glial cell line-derived neutrorophic factor (GDNF), the ligand that binds to the 
GFRA1/RET co-receptors to support undifferentiated spermatogonia. Studies published 
in 2014 demonstrate the PTM cells as a secondary source of GDNF in neonatal testis 
[66, 67]. 
Unfortunately, we as a field have a limited understanding of all the factors 
involved in establishment and maintenance of SSC niche. I believe that this work will 
provide a number of tools that may result in acquiring better knowledge of niche 
microenvironment is the testis.  
 
Meiosis of Spermatocytes  
 Meiosis in spermatogenesis is characterized by a single round of DNA replication 
followed by two cell division, in which one diploid cell gives rise to four haploid cells. 
Cells before the first division are termed primary spermatocytes, and before second 
division are named secondary spermatocytes. Primary spermatocytes are the largest 
germ cells within the germinal epithelium and can first be observed at P8 in the mouse 
testis. The biggest difference between mitotic and meiotic phases is the prophase of the 
first meiotic division. In the mouse, this stage lasts several day, during which genetic 
recombination takes place. The sub-stages of meiotic prophase are preleptotene, 
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leptotene, zygotene, pachytene, diplotene, and a brief [68] (Fig. 2). During the prophase 
of meiosis  a number of events occur. Homologous chromosomes must find each other, 
align, and then synapse. At least one recombination event must occur within each 
homolog pair, and it must be highly regulated to ensure proper exiting of meiotic 
prophase [69]. After the first meiotic division, each primary spermatocyte produces two 
secondary spermatocytes. The secondary spermatocytes are short-lived, which 
explains why they are seldom observed in testicular biopsies. Each secondary 
spermatocyte undergoes quick division to become two haploid round cells, termed 
spermatids [70]. The two maturation divisions of each spermatocyte result in production 
of four spermatids, which will undergo a process called spermiogenesis. 
 
Spermiogenesis  
Spermiogenesis is the term describing the final stages of spermatogenesis that 
occur in the seminiferous epithelium; it is during this phase that postmeiotic haploid 
round spermatids undergo the morphogenetic transformations that will result in the 
formation of spermatozoa. During this process, nucleosomal chromatin is transformed 
into compacted chromatin fibers by the replacement of histones with transition protein 
which are in turn replaced by protamines [54]. The spermatid ceases active gene 
transcription as nucleosomes disappear and the chromatin is remodeled and 
compacted.  Another significant event occurring during spermiogenesis is the assembly 
of sperm flagellum. Soon after the completion of meiosis, a major of component of 
flagellum, the axoneme, can be observed. As elongation of spermatids continues, the 
additional structures necessary for flagellum functions (mitochondrial sheath, fibrous 
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sheath) are assembled  around the central axoneme [55]. At the conclusion of the 
maturation process of spermiogenesis, a partial extrusion of cytoplasm into the tubular 
lumen occurs, and this extruded cytoplasm is termed a residual body [56]. The final 
product of spermiogenesis is spermatozoa, a cell with a unique shape that is suitable for 
the transport to the female gamete.  
 
When spermatogenesis goes awry: Male infertility 
 Infertility is a disease of the reproductive system defined in humans by the 
failure to achieve pregnancy after 12 months of regular unprotected sexual intercourse 
[57]. Infertility affects nearly 80 million couples worldwide, and the male partner is 
responsible for approximately 50% of these cases [58-60] (Figure 3). Male infertility is 
most often accompanied by deficits (either singly or in combination) in sperm 
concentration and motility as well as by defective morphology. These conditions have 
been described using terms such as azoospermia (absence of sperm in the ejaculate), 
idiopathic oligozoospermia (sperm numbers below 15 million/ml), asthenozoospermia 
(reduced sperm motility), and aspermia (ejaculation failure) [61]. A combination of two 
pathologies such asthenozoospermia and oligozoospermia can be often observed in 
infertile males [62]. Azoospermia is defined as the absence of sperm in the ejaculate 
and effects approximately 1% of male population, and 15% of infertile men. It can be 
subcategorized into obstructive azoospermia (OA) and non-obstructive azoospermia 
(NOA). In OA, patients have normal spermatogenesis, exocrine and endocrine function, 
but have a physical blockage that prevents the release of sperm. OA accounts for 
approximately 40% of azoospermia cases [63], but can be surgically treated by 
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removing the blockage. NOA is defined as no sperm in the ejaculate, which results from 
a failure of spermatogenesis, and is considered to be the most severe form of male 
infertility, and the number of treatments is very limited due to lack of understanding of 
specific mechanism of spermatogenesis. Oligozoospermia refers to a low sperm 
concentration due to failure of primary spermatocytes to progress in development. The 
exact cause of spermatogenic maturation arrest is not understood, but several factors 
such as heat stress and chromosomal failure may play a role [64].   
The incidence of male infertility has risen in developed countries over the past 50 
years [65]. Therefore, there is an increasing interest in defining the underlying 
environmental and genetic factors that are responsible, although the number of 
substances definitively proven to have negative effects on spermatogenesis is currently 
low. Exposure to various environmental agents, such as cadmium, mercury, dioxin, and 
bisphenol A (BPA) have all been shown to have a detrimental effect on male 
reproductive capacity in both humans and rodents [66, 67]. Unhealthy lifestyle, smoking,  
[68], obesity, and environmental toxicants are also all known factors that can negatively 
impact male infertility.   
There is a great number of genetic causes that are thought to underlie male 
infertility. These include genes involved in a variety of physiological processes, such as 
spermatogenesis [69], and have been a major focus of research. Chromosomal 
anomalies are the most well-known genetic contributors leading to male infertility, and 
are present in an estimated 5% of infertile men [70]. Chromosomal aberrations, either 
structural or numerical, have profound effects on fertility and are often observed in 
azoospermia and severe oligospermia, at frequencies ranging from 10%-24% and from 
 
 14 
1%-13%, respectively [71, 72]. The second most common genetic cause of male 
infertility is  microdeletions of the azoospermia factor (AZF) regions of the Y 
chromosome [73]. Microdeletions in this region cause defects in spermatogenesis, that 
leads to development of azoospermia and oligozoospermia. AZF is a locus on the Y-
chromosome that contains 16 coding genes that are required for normal 
spermatogenesis, code for RNA binding proteins, and may be involved in RNA splicing, 
and RNA metabolism [74]. These AZF microdeletions occur in 3-15% of azoospermic or 
oligozoospermic men [75]. 
Model organisms, especially rodents, have been used to define the molecular 
and cellular pathways regulating normal male reproduction. It is only by gaining a more 
complete understanding of spermatogenesis that we can identify the underlying causes 
of male infertility and begin to develop clinical approaches to treat this disease.  
 
How can we design a drug to block spermatogenesis: Male contraception 
With the Earth’s population significantly rising in recent decades, there is a need 
for readily available, inexpensive, effective, and safe male contraceptive. Currently, the 
2 most commonly used methods of male contraception are condoms and vasectomy. 
The condom provides a non-surgical physical method of contraception that has been 
widely used for a long time, and has the added benefit of preventing sexually 
transmitted diseases. However, condoms are not optimal choices due to breakage, 
incorrect use, and poor long-term use [76]. A vasectomy is a surgical method of male 
contraception that can be performed under local anesthesia. Briefly, the vas deferens 
are isolated and brought out from the scrotum through an incision followed by division 
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and ligation. This technique has been optimized, and currently minimally-invasive 
options are available. A “no scalpel technique” minimizes blood loss and reduces the 
possibility of infection [77]. While this method is effective and the rate of unwanted 
pregnancy is about 1% [78], it has a number of disadvantages. The reversibility of this 
procedure is not always successful [79]. With the time elapsed from the procedure 
increase, the reversibility rate decreases. Many patients may also develop anti sperm 
antibodies, which may potentially bring down the fertility rate. Other common 
complication of the vasectomy are significant testicular discomfort [80], hematoma 
formation (2%), sperm granulomas (10%-30%), chronic orchalgia (12%-52%), and 
infection (3.4%) [81].  
As a modern alternative to external and surgical contraceptives, researchers are 
currently exploring ways to reversibly block spermatogenesis using pharmaceutical 
approaches to target genes or signaling pathways required for sperm production. The 
selectivity, specificity, and lesser side effects of non-hormonal contraceptives make 
these approaches more attractive compare to hormonal alternatives. For example, 
indenopyridines are compounds that have been used experimentally to alter expression 
of Sertoli-germ cell adherens junction proteins, which may result in germ cell loss [82]. It 
is also used in combination with a gonadotropin-releasing hormone (GnRH) antagonist 
in studies with monkeys, and was shown to have a specific antispermatogenic effect, 
which can be reversed under proposed conditions. This study also suggests that this 
compound can be potentially used as a nonhormonal oral male contraceptive [83]. 
Another example of nonhormonal contraceptive is gossypol, a plant extract derived from 
the cotton plant. In study done of Chinese men, this approach showed an adequate 
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suppression of sperm concentration to levels required for contraceptive [84]. However, 
the effect of gossypol was irreversible in 20% of the patients, and other dose-dependent 
side effects included hypokalemia and periodic paralysis. Literature shows, that while 
we are getting closer to discovering nonhormonal molecular targets that can be used to 
design a pharmaceutical male contraceptive with limited side-effects, there is still a 
large amount of work to be done.  
 
Techniques to study spermatogenesis 
 Spermatogenesis is a technically challenging process to study, and this has 
dissuaded many labs from studying the process, and has hampered progress by labs 
who do study spermatogenesis full-time such as ours. There are several limitations that 
must be overcome. First, there is no currently-accepted cell line for in vitro studies. 
Researchers have generated several spermatogonial lines, but none of them faithfully 
represent in vivo spermatogonia. Second, spermatogenesis has not been recapitulated 
in vitro or using ex vivo organ culture systems. Third, it is difficult-to-impossible to 
isolate individual germ cell types because the testis contains a complex mixture of both 
germ and somatic cell types whose ratios change dramatically during development. At 
any age, biochemical studies on germ cells cannot be performed or interpreted using 
whole testis cell suspensions or lysates. Instead, they must be done on isolated germ 
cell populations. In the neonatal testis, the germline makes up a relatively small 
proportion of the overall cell population [42]. In the adult testis, the germline makes up 
~90% of the cells within the testis; however, all germ cell types are present, from SSCs 
to testicular sperm. To-date, several approaches have been used to isolate distinct cell 
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types. These include STA-PUT, magnetic-activated cell sorting (MACS), and flow 
cytometry. Each of these approaches has limited utility, and will be discussed below. 
 
STA-PUT 
This technique was introduced in the 1970s, and is a means to isolate cells from 
a single cell suspension using differential velocity sedimentation [85]. Sedimentation 
occurs through a linear BSA gradient, and separates cells based on their size and 
mass; this technique can yield purities of some, but not all cell types of interest 
approaching 90% [86]. Researchers have taken advantage of the significant differences 
in relative sizes of specific germ cell types (e.g. prospermatogonia, pachytene 
spermatocytes, round spermatids) at specific time points during development to isolate 
relatively pure cell populations. In our laboratory, we routinely isolate tens of millions of 
pachytene spermatocytes (~85% purity) and spermatids (~90% purity) using only a few 
adult mice. The viable spermatogeneic isolated by STA-PUT can be maintained in 
culture, but not expanded (since they are post-mitotic), and they can be used for the 
isolation of macromolecules such as mRNAs and protein. The significant disadvantages 
of STA-PUT include the following: 1 – it cannot be used to isolate cells unless they are 
significantly larger or smaller than other cell types; 2 – it requires specialized glassware 
and equipment; 3 – it requires an expert eye to discriminate spermatogenic cell types 
using light microscopy. 
 
Magnetic-activated cell sorting (MACS)  
MACS is another powerful tool used for isolation of viable minority cell 
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populations from single cell suspensions. To isolate enriched cell populations, 
researchers must have a specific antibody against a unique cell surface-localized 
protein that can be bound in live cells. This antibody is conjugated to a magnetic bead; 
after incubating cells with this antibody-bead conjugate, the suspension is passed 
through a specialized column to which the magnetic bead will bind. Afterwards, multiple 
washes eliminate unbound cells, and finally the bound cells are eluted from the column  
[87]. MACS-enriched cells are viable, and can be used for initiating cultures; this has 
been done with spermatogonia [88]. Spermatogonia have been isolated using 
antibodies recognizing cell surface proteins including the KIT receptor tyrosine kinase 
(differentiating spermatogonia [89, 90]) as well as THY1 (undifferentiated 
spermatogonia) [91]. Although both of these antibodies capture spermatogonia, they 
also recover significant numbers of interstitial somatic cells, which also express both 
KIT and THY1. MACS is currently not useful for isolating spermatocytes and 
spermatids, as appropriate cell surface proteins for immunocapture have not been 
identified [92].  
 
Flow cytometry  
Flow cytometry is a well-established technique in biomedical research. While this 
revolutionary technology combines several concepts, the originality of this technique 
resides in observation of aligned cells one behind another into a fluid sheath first 
described in 1934 [93]. In 1980s, optical emission systems appeared, which led to 
creation of the first high speed cell sorter, that was used for human chromosome 
separation and up to three color analysis. By the 1990s, flow cytometer capacity 
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increased, allowing the simultaneous measurement of 7 fluorophores. Now, 84 years 
from the starting point, this highly sophisticated technology is capable of simultaneously 
detecting up to 14 parameters (size, shape, granularity, pigments, autofluorescence, 
DNA content, apoptosis, membrane structures, internal and external receptors, 
physiological activity, transfection efficiency, time, and cell/particle concentration) [94].  
Another important task that can be accomplished by flow cytometer is cell sorting. A 
specialized flow cytometer has the ability to physically isolate cells of interest with high 
degrees of purity into separate collection tubes based one or more parameters listed 
above from a heterogeneous cell mixture.  
Today, this technology has a seemingly limitless number of applications. Flow 
cytometry is often used to characterize disease in animal research laboratories and 
clinical settings [95]. Some of the common uses are phenotyping (the identification of 
specific observable characteristics), analysis of DNA abnormalities, identification of 
tumor cell surface receptors, and detection of specific immunophenotypic characteristics 
of different hematologic cancers. Flow cytometry has been successfully employed to 
sort fixed or live germ cell populations based on DNA content [53], and mitochondrial 
mass or activity [96, 97]. Several germ cell types such as primary spermatocytes, 
secondary spermatocytes, round, and elongated spermatids were isolated by flow 
cytometry, using Bis-benzamide Hoechst 33342 (Ho) dye to discriminate between these 
cell types [98]. The Ho dye allows the detection of variations in chromatin structure and 
DNA content [99]. What makes flow cytometry stand out from other technologies is the 
ability to analyze, measure, and study heterogeneous populations of cells, one cell at a 
time, and allows the identification of various cell types without loss of the information 
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[100]. The drawbacks of this technique include: 1 – expensive instrumentation; 2 – 
necessity for highly-trained operators; 3 –results in some cell loss when focused on 
purity; and 4 – it provides little information on intra-cellular distributions. Our laboratory 
has access to the ECU flow cytometry and cell sorting facility, and therefore this method 
is available to us to isolate different spermatogenic populations.  
 
Transgenic mice enable FACS 
Animal research was revolutionized by the development of transgenic animal 
technology, which arose from the pioneering work of Drs. Rudolf Jaenisch and Ralph 
Brinster. In independent experiments, they successfully transferred exogenous DNA 
into early developing embryos [101]. These early advances set the stage for the 
generation of a multitude of increasingly sophisticated transgenic mouse models, from 
those with random insertion of reporter genes to conditional and whole-body 
“knockouts” (KO) or “knock-ins” (KI) at specific gene loci.  
The utilization of reporter transgenes has allowed for the development of mouse 
lines in which specific populations of cells can be identified by expression of a 
fluorescent marker, usually GFP, or alternatives, such as RFP (tdTomato, mCherry), 
YFP, and CFP.  The Green fluorescent protein (GFP) is a 238 amino acid protein 
endogenous to the bioluminescent jellyfish Aequorea Victoria [102]. Dr. Shimomura first 
isolated the gene encoding GFP from these jellyfish in 1992, and now scientists have 
adopted it as a powerful tool for monitoring gene expression and protein localization in 
cells and organisms [103]. This protein is stable, and can be detected using flow 
cytometry and fluorescent microscopy [104]. One of the key features of GFP is its ability 
to generate the intrinsic chromophore without cofactors or enzymatic components [105].   
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Nowadays, GFP and its variants and homologs of different colors are used in a 
variety of application to study the organization and function of living systems. Enhanced 
green fluorescent protein (EGFP) is a newer GFP variant that has numerous 
advantages over other reporter markers [106]. It does not require additional cofactors, 
gene products, or substrates [107] to fluoresce 20 to 35 brighter than the wild-type GFP 
[108]. Tandem dimer tomato (tdTomato) is a red fluorescent protein that under right 
conditions shows equal or brighter photostability than green fluorescent protein (GFP) 
[109]. TdTomato has been successfully used for multiple applications. It was used as a 
promoter reporter  for GEX3 promoter to study pollen [110]. Tdtomato was also 
employed as a fusion protein [111], and successfully used to generate transgenic 
mouse models [112]. The advantages of transgenic mouse lines expressing fluorescent 
proteins are numerous. Reporter transgenes make it possible to perform live tissue 
“whole mount” analyses, allowing for identification of certain cell subtypes that are 
expressing the factor of interest without the disruption that is caused by sectioning of 
tissues [9]. The development of transgenic mouse line also allows for FACS isolation of 
selected cell populations. Transgenic mouse models analyzed in this work are focused 
on employing these advantages to broaden our understanding of spermatogenesis.  
 
Germline-expressed fluorescent reporter strains 
  Scientists studying germ cell biology have created a variety of transgenic mouse 
models with the intention of fluorescently labeling specific germ cell types in mammalian 
testis (Table 1.). Unfortunately, all current models have significant flaws; most have 
been discarded, and only a precious few remain in use. One of the best models for 
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isolating postnatal spermatogonia, the Id4-eGfp line, is in current use in our laboratory. 
These mice were generated by Dr. Oatley’s laboratory (Washington State University) 
via pronuclear injection and “mimic” the ID4 protein expression. Briefly, a 17-kb 
fragment containing the promoter of the mouse Id4 gene was captured from a BAC 
clone. Then, an eGfp-Ura3 cassette was inserted in-frame of exon 1, deleting 
nucleotides 13-29. The transgene construct was then used for pronuclear injection to 
generate founder lines on an FVB genetic background. From five transgenic founder 
lines, one was chosen for expansion and backcrossed onto the C57BL/6J genetic 
background [9]. These Id4-eGfp mice have predominant expression of EGFP in 
undifferentiated spermatogonia in the neonatal testis. Additionally, the intensity of EGFP 
is linked to spermatogonial fate. The ID4-EGFPbright population is enriched for SSCs; all 
SSCs appear to be Id4-EGFPbright, but not all ID4-EGFPbright spermatogonia are SSCs. 
The ID4-EGFPdim population also contains undifferentiated spermatogonia, but this 
population contains very few SSCs; these represent the proliferating progenitor 
population. STRA8+/KIT+ differentiating spermatogonia are ID4-EGFP- [9]. Based on 
this expression pattern, this model is useful for isolation of SSCs and progenitor 
spermatogonia via FACS, but does not allow for isolation of differentiating 
spermatogonia. For our laboratory, a better model would express a fluorescent reporter 
in all spermatogonial cell types, thus allowing the isolation of SSCs and progenitor and 
differentiating spermatogonia via FACS.  
 
Summary 
Due to the variation in abundance of somatic (Sertoli, Leydig, epithelial, and 
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myeloid cells) and spermatogenic (spermatogonia, spermatocytes, round spermatids, 
condensing spermatids, and spermatozoa) cells, it is challenging to study SSC 
proliferation and differentiation [10]. The ability to isolate germ cells at each point during 
the first wave of spermatogenesis would provide our laboratory with the ability to isolate 
discrete spermatogonial populations and perform a wide array of complex molecular 
assays such as proteomics, metabolomics, and transcriptomics.  
 
 In the work described in this thesis, I analyzed 5 different transgenic mouse 
models, each with putative expression of recombinant fluorescent protein in the male 
germline. The impetus for these efforts was to identify a powerful tool for the isolation of 
live spermatogonia to advance our studies on mouse spermatogenesis. The ideal model 
will have discrete expression of fluorescent protein confined to spermatogonia and 
exhibit bright epifluorescence in both live and fixed cells. These characteristics will 
enable our laboratory to perform advanced biochemical assays and make advances 



















Promoter Fluorophore Expressing Cells References 
Dazl GFP spermatocyte, 
spermatids 
[113] 
Sohlh1 mCherry spermatogonia [114] 
Dppa3/Stella GFP PGCs  
Pou5f1/Oct4 GFP PGCs [115] 
Ifitm3  PGCs [116] 
Id4 EGFP spermatogonia, 
spermatocytes, spermatids 
[9] 
Sycp1-Cre N/A spermatocytes [117] 







Figure 1. Overview of Mammalian Spermatogenesis. The developmental 
progression of germ cells in the testis, that begin as spermatogonia and can either 
remain undifferentiated as SSC or progenitors or differentiate in response to RA and 
enter meiosis as spermatocytes. After meiosis, spermatids undergo morphogenetic 
















Figure 2. Stages of spermatogenesis and steps of spermiogenesis in the mouse. 
The specific phases of cell development designated by the symbols are: type A 
spermatogonia in mitosis (mIn), intermediate spermatogonia in mitosis (Inm), type B 
spermatogonia (B), type B spermatogonia in mitosis (Bm), preleptotene spermatocytes 
(Pl), leptotene spermatocytes (L), zygotene spermatocytes (Z), pachytene 
spermatocytes (P), diplotene spermatocytes (D) and secondary spermatocytes in 



































































Figure 3. World map displaying percentages of infertility cases per region that are 




























CHAPTER 2: Materials and Methods 
Animal Handling and Genotyping 
All animal procedures were carried out using protocols prepared in 
accordance with the National Research Council Guide for the Care and Use of 
Laboratory Animals and approved by the Animal Care and Use Committee of East 
Carolina University (AUP #A198). Euthanasia of neonatal and juvenile mice up to P7 
was performed by decapitation, and euthanasia of mice older than P7 was done by 
CO2 asphyxiation followed by cervical dislocation or decapitation.  
 
Ddx4-tdTomato 
Ddx4-tdTomato transgenic mice carrying one copy of the construct were 
created by Cyagen Bioscences, Inc. The 8419 bp regular plasmid gene expression 
vector was inserted downstream of Ddx4/Vasa promoter. Three founder lines were 
generated by pronuclear microinjection. Line #3 was used to propagate the strain.  
TdTomato alleles were identified by PCR-based genotyping using the following 
primers: tdTomato forward 5′- CTACACCATCGTGGAACAGTACGA, tdTomato 
reverse 5′-ACACCTCCCCCTGAACCTGAAAC. PCR conditions: Denaturation Temp: 
94°C for 30 sec, annealing Temp: 60°C for 30 sec, extension: 72°C for 30 sec, 




Rosa26-EGFP expressing EGFP were created by crossing homozygous 
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female mice carrying a floxed EGFP allele (#004077, The Jackson Laboratory) with 
young (<P60) male mice carrying the Ddx4-Cre transgene (#006954, The Jackson 
Laboratory.) PCR conditions: Denaturation Temp: 94°C for 30 sec, annealing Temp: 
60°C for 30 sec, extension: 72°C for 30 sec, number of cycles: 35. The resulting 
transgenic pups were on a C57Bl/6 background 
 
DNA isolation  
 Approximately 0.5 mm of tail tissue was carefully snipped and placed into 1.5 
ml microfuge tubes with tight-fitting caps. 0.5 ml of DNA digestion buffer (1M Tris pH 
8, 5M NaCl, 0.5M EDTA, SDS) with proteinase K was added to 1 mg/ml final 
concentration and incubated at 55°C overnight while shaking at 900 rpm. Samples 
were spun at 13,000 rpm, and 500 µl of phenol:chloroform:isoamyl alcohol (25:24:1) 
was added. Samples were spun 13,000 rpm for 10 min to separate aqueous (top) 
from organic (bottom) layers. The top aqueous layer was removed and transferred 
into 1.5 ml microfuge tubes. 500 µl of chloroform was added and tubes were spun at 
13,000 rpm for 10 min. Two layers were separated again, and the top aqueous layer 
was transferred to a 1.5 ml microfuge tube. 750 µl of 100% ethanol was added to 
each tube and mixed by inverting multiple times (~20) to precipitate DNA. Tubes 
were spun at 13,000 rpm for 10 min and liquid was carefully removed without 
disturbing the pellet on the bottom of a tube. Pellets were washed twice with 750 µl 
of 80% ethanol to remove salts. Tubes were spun at 13,000 rpm for 1 min, and 
remaining ethanol was removed. Pellets were dried for 15 min at room temperature 
until all residual ethanol had evaporated. 500 µl of Tris pH 7.5 was added to each 
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pellet and vortexed. Tubes were incubated at 37°C with shaking at 900 rpm 
overnight. The quantity of DNA was assessed using a NanoDrop™ 2000 
spectrophotometer. 
 
Indirect immunofluorescence (IIF) staining 
Testes were immersion-fixed in fresh 4% paraformaldehyde, washed in 1X 
PBS, incubated overnight in 30% sucrose at 4°C, and frozen in O.C.T. Five 
micrometer sections were placed on slides, and each section was incubated in 
blocking reagent (1X PBS containing 3% BSA+ 0.1% Triton X-100) for 30 min at 
room temperature. Primary antibodies were diluted with blocking reagent and 
incubated on tissue sections for 1 hr at room temperature. The primary antibodies 
used are listed in Table 2. Primary antibody was omitted from one section in each 
technical replicate to serve as a negative control. Following three stringency washes 
in the wash buffer (1X PBS + 0.1% Triton X-100), sections were incubated in 
blocking reagent containing secondary antibody (Alexa Fluor-405, -488, -555, or - 
559, each at a 1:500 dilution, Invitrogen) and/ or phalloidin-635 (1:500, Invitrogen) for 
1 hr at room temperature. Stringency washes were performed as above. Coverslips 
were mounted using Vectastain containing DAPI (Vector Laboratories). IIF on 
isolated cells was performed using the same protocol.  
Whole mount indirect immunofluorescence was performed using the same 
steps as above, but with different time points. All washes and incubations were 
performed on the tube rocker. Tissues were permeabilized in wash buffer for 30 min, 
incubated in block buffer for 1 hr, followed by incubation in block buffer containing 
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primary antibodies overnight at 4°C. Tissues were washed in wash buffer 3 times for 
30 min each time, and then incubated in block buffer containing secondary 
antibodies for 3 hr. Tissues were again washed in wash buffer 3 times for 30 min 
each time, then placed on a slide, Fluoroshield Medium with DAPI (Abcam 
#ab104139) diluted 1:1 in 1X PBS was added to cover the tissue, and a coverslip 
was placed on top and sealed with nail polish.  
 
Testicular single cell suspension 
Pups or adult mice were euthanized and testes were carefully removed and 
placed in a warmed dish containing Enriched Krebs-Ringer Bicarbonate Medium 
(EKRB). Testes were detunicated beneath a dissecting stereomicroscope, and 
placed into a 15 ml conical tube containing 4.5 ml Trypsin + 0.5 ml of 
Deoxyribonuclease I (DNase I). The solution was repeatedly drawn and expelled to 
begin breaking up the tissue. The tube with the solution was placed into 37°C water 
bath for 3 min. 1 ml of DNase I was added to the solution and pipetted repeatedly to 
break up the tissue as above. This procedure was done twice. 1 ml of FBS was 
added to stop the digestion of tissues. The mixture was filtered through a 40 µm 
sieve (Falcon #352340) into a 50 ml conical tube. The initial 15 ml conical tube was 
rinsed with 2 ml of Hank’s Balanced Salt Solution (HBSS). The solution was 
transferred into a new sterile 15 ml conical tube. The cell suspension was centrifuged 
at 500 x g for 7 min. Cells were resuspended in sorting buffer 
(FBS/EDTA/HEPES/PBS) or DMEM with penicillin-streptomycin (pen-strep). Cells 
were counted using the hemocytometer and either plated or used for fluorescent 
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activated cell sorting (FACS, described below).  
 
Fluorescent activated cell sorting (FACS) 
FACS was performed by East Carolina University Flow Cytometry/Confocal 
Microscopy Core Facility using a Becton Dickinson AriaFusion Cell Sorter. This 




Isolated cells were seeded on fibronectin-coated 6-, 12-, and 96-well plates at 
the density of 2 x 106, 1 x 106, and 0.05 x 106 respectively. Cells were also plated on 
fibronectin-coated coverslips at the density of 2 x 106, and incubated in 37ºC 
overnight. Cells were then washed with PBS, and fixed with 4% PFA for 15 minutes.  
 
Imaging 
Images of live tissue were obtained using Zeiss fluorescent microscope. 
Images of stained tissues were obtained using a Fluoview FV1000 laser scanning 












Antibody Vendor (Catalog 
Number) 
Dilution 
-TRA98 Abcam (ab82427) 1:1000 
-DDX4 R&D Systems (AF2030) 1:800 
-GATA4 R&D Systems (AF2606) 1:500 
-PLZF/ZBTB16 Abcam (ab18949) 1:800 
-UCHL1 Cell Signaling (13179) 1:1000 
-KIT Cell Signaling (3074) 1:1000 
-GFRA1 R&D Systems (AF560) 1:800 
 
 
CHAPTER 3: Results 
  
Npy-GFP  
The first transgenic mouse model I investigated was ‘neuropeptide Y’ (Npy)-GFP. 
These mice were housed in Dr. Hu Huang’s laboratory (Department of Kinesiology, East 
Carolina University) by inserting a humanized Renilla GFP (hrGFP, Stratagene) 
sequence into the translational start site of the mouse Npy gene. Following isolation of 
the transgenic construct NPY-GFP, the transgene was used for pronuclear injection into 
fertilized one-cell stage FVB embryos. One line was chosen to propagation and these 
mice were bred on C57BL/6 genetic background [123].  
Neuropeptide Y is a 36 amino acid peptide containing several tyrosine residues 
synthesized primarily in neurons in the brain [124]. In the hippocampus, NPY has been 
suggested to function as an endogenous anti-epileptic peptide [125]. In the 
hypothalamus, neurons containing NPY are thought to be critical for energy 
homeostasis [126]. Curiously, Npy mRNAs were also detected in the testis, potentially 
in Leydig cells and Sertoli cells [127, 128]. In addition, microarray results revealed that 
Npy mRNA levels decreased from P0-P6, a pattern often observed for genes expressed 
in SSCs; the pool of germ cells with SSC capacity is thought to diminish over this 
interval [129]. We considered the possibility that NPY was expressed in a subset of 
male germ cells during testis development, and decided to assess whether NPY-GFP is 
expressed in a subset of germ cells.  
We analyzed testicular tissues from 2 adult (P>60) Npy-GFP hemizygous mice. 
These tissues were fixed, sectioned, and stained with DAPI in accordance with our 
 
 38 
protocols. Upon examination, I observed that GFP was detectable in peritubular myoid 
cells and, to a lesser degree, in interstitial Leydig cells (Fig. 4B-D). Unfortunately, GFP 
was not detectable in any germ cells. While this mouse line is not suitable for our area 
of research, it may be successfully employed by investigators interested in isolating 
somatic Leydig and peritubular myoid cells.  
 
Ddx4-tdTomato 
The second transgenic mouse model I investigated was one produced recently 
by the Geyer laboratory. A 1.4 kb fragment of the proximal ‘DEAD-Box Helicase 4’ 
(Ddx4) promoter, which was previously shown to successfully direct male germline 
expression [130], was placed upstream of the coding sequence for tdTomato. The Ddx4 
gene is conserved across multiple species and is specifically expressed in the germline 
of Drosophila [131], zebrafish [132], monkeys [133], mice [134], and humans [130]. The 
endogenous Ddx4 gene is expressed as early as E15.5 in the mouse male germline in 
prospermatogonia, and is expressed to varying levels throughout the remainder of 
spermatogenesis [135]. We hypothesized that tdTomato would be detectable in the 
same germ cells expressing endogenous DDX4, and that expression would be 
sustained throughout development. 
Three transgenic Ddx4-tdTomato founder mice were generated by pronuclear 
microinjection by Cyagen Biosciences. These founders were bred to WT C57Bl/6 mice 
to expand 3 lines with unique transgene integration sites. Not unexpectedly, we 
discovered considerable differences in the expression of tdTomato in the different 
founder lines. Adult testes from line 1 had no detectable tdTomato expression, while 
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those from mice in lines 2 and 3 had bright tdTomato epifluorescence (Fig. 5). Line 2 
failed to produce a sufficient number of transgenic male offspring and was discarded 
from the study. Offspring from line 3 were used to expand a colony for further 
evaluation.  
Surprisingly, Ddx4-tdTomato+ testes had no detectable tdTomato protein at P6, 
P8, and P10. However, expression became detectable at P15, and increased as the 
mice aged (Fig. 6A-O). I used adult mice to generate single cell suspensions for FACS 
to separate tdTomato+ and tdTomato- cells. Adult testes appeared to have the highest 
tdTomato expression levels (Fig. 6M-O). Sorting and plating adult tdTomato testicular 
cells revealed an abundance of tdTomato+ germ cells and residual bodies. Indirect 
immunofluorescence (IIF) on isolated cells showed these observed residual bodies 
lacked nuclei (Fig. 7D). Also, not all cells were tdTomato+ post sort (Fig. 7B-D). We 
conclude that this model did not recapitulate our expected expression pattern for 
tdTomato. This model did not produce desired results, and therefore will not be used in 
future studies in our laboratory to isolate germ cells.  
 
Rosa26-EGFP;Ddx4-Cre 
 The third transgenic mouse model I investigated was one that I generated by 
crossing 2 strains of mice available from the Jackson Laboratory: Ddx4-Cre (stock 
#006954) and Rosa26-EGFP (stock #004077). The latter has a transgene within the 
Rosa26 locus, which is on chromosome 6 and is commonly used as a site for 
integration of transgene constructs to achieve ubiquitous or conditional gene expression 
in mice [136]. Fluorescence in these mice is predicted to occur following Cre-mediated 
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excision of a lox-STOP-lox sequence; this brings the promoter in juxtaposition with the 
EGFP coding sequence (Fig. 8).  
We predicted that Ddx4-Cre expression early in the male germline would drive 
germline expression of EGFP beginning in fetal prospermatogonia and then in all 
subsequent germ cells. I first examined freshly dissected live seminiferous cords of P6 
mice under the fluorescent microscope to detect EGFP a high expression of fluorescent 
protein in these tissues. I next stained PFA-fixed frozen sections from P6 mice with the 
pan germ cell marker TRA98 and observed that EGFP was detectable only in 
spermatogonia (Figure 9A-D). As expected, EGFP was not detected in testes of WT 
littermate controls.  
One significant disadvantage of the Ddx4-Cre line is that Cre-donating males 
must be young; after ~P80, Cre expression is not tightly restricted to the germline. In 
analyzing multiple litters from the same crosses, we observed that EGFP became 
detectable in both germ cells and somatic cells as the Cre-donating sire aged. In 
agreement with expected Mendelian ratios, the number of transgenic male pups was 
limited per litter (n3). This number is insufficient to provide enough cells after FACS.  
Altogether, we conclude that the Rosa26-EGFP;Ddx4-Cre model is suitable for isolation 
of male germ cells, but it is not an optimal model because few usable litters are 
produced per breeder cage setup, and few pups will be produced for isolating cells. 
 
Dnd1-EGFP  
          The fourth transgenic mouse model I investigated was one generated in Blanche 
Capel’s laboratory at Duke University. Her laboratory is interested in understanding 
early steps in testis development by defining the molecular mechanisms underlying the 
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events in somatic cells that commit bipotential gonad to testis or ovarian fate. In one 
recent study, Dr. Capel’s laboratory created mice carrying a transgene with the Dnd1 
promoter directly upstream of EGFP. These mice were created by CRISPR-mediated 
knockin of EGFP into the Dnd1 locus. The insertion of EGFP did not affect DND1 
function, and homozygous mice were viable and fertile (Capel, personal 
communication). Having a homozygous mouse model would be ideal for our 
laboratory’s studies, because it would save time and resources on genotyping 
procedures, as well as provide us with number of animals required to perform cell 
sorting. 
 The ‘Dead-end gene’ (Dnd1) gene encodes two RNA binding protein isoforms, α 
and β, due to alternative splicing of transcripts. It is expressed in germ cells as early as 
E7.25 and was shown to be required for survival of PGCs [137]. The inactivation of this 
gene leads to Ter mutant mouse strain, which results in germ cell deficiency, sterility, 
and development of TGCTs and results in PGC deficiency [138, 139].  
 We expected Dnd1-EGFP mice to exhibit germ cell-specific expression of EGFP. 
To examine this, we obtained testes form mice at the following ages: P1, P3, P6, and 
P10. I fixed, sectioned, and stained these tissue in accordance with lab protocols. Upon 
examination I found that all ages express EGFP in both germ cells and Leydig cells 
(Fig. 10A-O). The EGFP signal was not as bright as we expected. P1 showed the 
brightest expression of EGFP in germ cells, and it appears that the intensity of the 
endogenous EGFP decreases with age. In Leydig cells, however, the expression 
remained unchanged.  
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 Based on low EGFP expression in germ cells and expression in Leydig cells, 
these mice do not appear to be suitable for FACS until a separation of tubular (germ 
cells and Sertoli cells) and extratubular (Leydig cells and peritubular myoid cells) 
components is successfully done. A number of protocols have been developed over the 
years that allow this separation using collagenase treatments. Briefly, after removing the 
testes’ tunica albuginea, seminiferous tubules are dissociated and transferred into the 
collagenase solution. This allows the initial separation of seminiferous tubules from the 
interstitium, as the tubules rapidly sink to form a pellet at the bottom of the tube, while 
the interstitial components remain in the supernatant.  
 This method does not work as well on neonatal testes. Since our laboratory is 
mostly interested in this phase of germline development, we often use P6 mouse pups 
as a source of testicular tissue. While the digestion protocol has been optimized for 
adult testis, the preferred concentration of the enzyme that can be used on neonatal 
testes is yet to be identified. We conclude that this model is most useful for isolation of 
germ cell in prentatal stages of development, but significant challenges currently 
prevent this line from being useful  for postnatal isolations.  
 
Uchl1-eGfp 
        The fifth transgenic mouse model I investigated was one generated in Dr. Pembe 
Ozdinler’s laboratory at Northwestern University.  Her laboratory is interested in 
understanding the cellular and molecular basis of selective neuronal vulnerability, and 
primarily focuses on  the corticospinal motor neurons (CSMN), the neurons that are 
important for the initiation and modulation of voluntary movement. Dr. Ozdinler’s 
laboratory created a fluorescent reporter mouse model with eGFP expression under 
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UCHL1 promoter that genetically labels CSMNs and a subpopulation of degeneration-
resistant spinal motor neurons in an ALS  [140]. The ‘Ubiquitin carboxyl-terminal 
hydrolase L1’ (Uchl1, also known as protein gene product (PGP) 9.5) gene encodes a 
deubiquitinating enzyme with ligase and hydrolase activities [141]. It is highly expressed 
in sensory and sympathetic ganglia [142, 143], retina [144], and has been used as a 
marker of neural elements. UCHL1 has also been localized to germ cells in multiple 
species, including dogs [145], pigs [146], cattle [147], and mice [148]. Studies done by 
Kon et al. in 1999 demonstrate the expression of UCHL1 in mouse testis specifically in 
spermatogonia in neonates, and in Sertoli cells in adult. [149].  In 2015, Dr. Ozdinler 
reported expression of UCHL1-EGFP in P30 testis from Uchl1-eGfp mice [150]. Taking 
these discoveries together, we expected a germ-cell specific expression of EGFP in 
neonatal testes of  Uchl1-eGfp mice. 
           This model was created by pronuclear injections. Briefly, a BAC clone encoding 
the UCHL1-eGFP was directly inserted into approximately 200 pro-nuclei of fertilized 
oocytes of C57BL/6 mice. Out of nine line expressing EGFP, three showed strong 
EGFP expression that was evident with consistent pattern and intensity of expression 
from litter to litter for >8 generations. We obtained testes from these mice to investigate 
the expression of EGFP in neonatal testis. Upon the examination of fixed and sectioned 
P6 testis, I observed that EGFP expression overlapped with UCHL1+ cells identified by 
IIF (Fig. 11 M-O). To extend these findings and determine whether EGFP was only 
expressed in germ cells, I stained P6 testis sections for the pan germ-cell marker 
TRA98 (Fig. 11D-F), and the Sertoli cell marker GATA4 (Fig. 11A-C). The expression of 
EGFP was strictly confined to TRA98+ cells, with no expression detectable in GATA4+ 
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Sertoli cells. This confirmed that UCHL1-EGFP+ cells were indeed germ cells and not 
somatic cells. I also observed a difference in EGFP brightness among germ cells. To 
determine whether brightness was associated with spermatogonial fate (stem, 
progenitor, or differentiating), I performed IIF using antibodies against markers of 
differentiating (KIT) and undifferentiated (GFRA1) spermatogonia. These analyses 
revealed that KIT+ spermatogonia were both UCHL1-EGFPbright and UCHL1-EGFPdim 
(Fig. 11G-I). However, only UCHL1-EGFPdim spermatogonia were GFRA1+ (Fig. 11J-L), 
suggesting that these cells are a subset of undifferentiated spermatogonia. We 
conclude that Uchl1-eGfp transgenic mouse model is an ideal candidate for isolating 
enriched populations of spermatogonia from developing mouse testes, and will serve as 




Figure 4. NPY-GFP is expressed in Leydig cells of adult Npy-Gfp mouse testis. (A) 
Structure of mammalian testis. (B-D) Representative images of  immunostaining for pan 
germ cell marker TRA98, and cell nuclei marker in cross-sections of seminiferous 
tubules from testes of adult Npy-Gfp mice. Solid lines identify Leydig cells. Dashed lines 
























Figure 5. DDX4-tdtomato is expressed in 2 out of 3 Ddx4-tdTomato founder lines. 
























































Figure 6. DDX4-tdTomato expression in germ cells increases with age (P8, P15, 
P21, P>60) in testes of  Ddx4-tdtomato mice.  (A,D,G,J,M) Representative images of 
fixed frozen sections stained with cell nuclei marker DAPI (blue) and endogenous 
tdTomato (red), (B,E,H,K,N) germ cell marker TRA98 (green) and DAPI (blue), 
(C,F,I,L,O) TRA98 (green), DAPI (blue) and endogenous tdTomato (red). Scale bar (in 






























































Figure 7. DDX4-tdTomato is expressed in germ cells and residual bodies after 
FACS of adult Ddx4-tdtomato testes. (A) Representative image of testicular single 
cell suspension. (B-D) Representative image of post-sort plating and fixation of DDX4-
tdtomato+ cells stained with cell nuclei marker DAPI (blue). Red is endogenous 






















































































































Figure 9. Rosa26-EGFP is specifically expressed in spermatogonia of P6 Rosa26-
EGFPxDdx4-Cre mice. (A) Representative images of immunofluorescence staining on 
frozen sections with pan germ cell marker TRA98 (red), GFP (green), and 4',6-
diamidino-2-phenylindole (DAPI) (blue), (B) GFP (green) and DAPI (blue), (C) TRA98 































































Figure 10. DND1-EGFP is expressed in both germ cells and Leydig cells of Dnd1-
EGFP mice at multiple stages of postnatal development. (A,D,G,J,M) 
Representative images of immunofluorescence staining on frozen section fixed with 
PFA using anti-GFP antibody (red) and DAPI (blue), (B,E,H,K,N) endogenous EGFP 
(green) and DAPI (blue), (C,F,I,L,O) anti-GFP (red), endogenous EGFP (green), and 




























Figure 11. UCHL1-EGFP is specifically expressed in spermatogonia in testes of 
P6 Uchl1-eGfp transgenic mice.  Representative images of immunofluorescence 
staining on frozen sections fixed in PFA using antibodies against (A-C) marker of Sertoli 
cells (GATA4), (D-F) pan germ cell marker (TRA98), (G-I) marker of spermatogonial 
differentiation (KIT), (J-L) marker of undifferentiated spermatogonia (GFRA1), and (M-





























































CHAPTER 4: Discussion 
 
The primary goal of this study was to evaluate five transgenic fluorescent 
reporter mouse models for their usefulness in isolating pure populations of germ cells 
by flow cytometry. Our field is currently lacking a reliable model for fluorescence-based 
isolation of germ cell populations, and this has impeded progress in addressing a 
number of outstanding questions. While a sizeable number of mouse models have 
been developed over the years, most of them do not work well. We found that, although 
4/5 of the models we investigated were either not suitable or not ideal for isolation of 
spermatogenic cells, all could be used to study some aspect of mammalian testis 
biology.  
The Npy-GFP mouse model lacks expression of GFP in germ cells. However, 
expression was observed in Leydig cells, suggesting a role for NPY in regulation of 
testis hormonal activity. Studies in rats have shown that NPY inhibits testosterone 
secretion in the rat testis [151]. In 2006, Terado et al. demonstrated the expression of 
endogenous NPY exclusively in the interstitial cells of the testes in mice, and our 
findings support that study.  While this model is not suitable for studies in our 
laboratory, it may be of interest to a laboratory studying the postnatal development of 
Leydig cells. 
The next transgenic mouse model (Ddx4-tdTomato) was expected to provide us 
with desirable expression of fluorescent protein in germ cells. Recently, a rat model was 
developed using a similar construct (Ddx4-GFP), and was successfully utilized for 
isolation of germ cells [152]. This rat model was also created via pronuclear injection, 
and one of the caveats of this approach is the transgene inserts randomly into the 
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genome and expression is therefore subject to position effect variegation (PEV). It is 
possible that the tdTomato expression variability we observed in our mice was due to 
construct insertion into the genome in a spot that was unfavorable for expression. This 
is not unexpected, that only approximately 10% or less of the founders generate 
offspring that contain the transgene [153]. This resulting mouse model is not useful in 
our laboratory to isolate germ cells. This method can be tested again, but we 
recommend obtaining more than three founders for each expression construct to 
increase chances of desirable expression.  
To continue our search for an ideal mouse model, we analyzed the Ddx4-
Cre;Rosa26-EGFP transgenic mouse model. A study done in rats in 2007 was focused 
on generation of rat line with genomic integration of a ROSA26-EGFP transgene with 
specfiic expression of EGFP in the germ cells [154]. Unlike our model that uses Cre-
mediated recombination of transgenic construct to direct EGFP expression, those rats 
were produced by microinjection of the transgene into pronuclei of rat embroys. 
Although our mice demonstrated desired germ cell-specific expression of EGFP and 
may be successfully used for isolation of spermatogonia, the efficient production of 
usable pups per litter (~2-3) is low, and would require a large number of breeder pairs. 
This makes this approach less than ideal for our laboratory. 
The Dnd1-eGfp transgenic mouse model, created at Duke University, is currently 
used by Dr. Capel’s laboratory to investigate fetal male germ cell development, and to 
study teratomas. Since these mice express EGFP in PGCs and prospermatogonia, and 
Dnd1 mRNAs are upregulated in neonatal testis, we expected to observe strong EGFP 
expression in neonatal spermatogonia. Although DND1-EGFP was detectable in germ 
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cells in testes of various ages (P1, P3, P6, P10, and P>60), it was also highly expressed 
in Leydig cells. These results suggest, that while it is possible to use this model for 
isolation of germ cells via FACS, additional experimental steps would be required to first 
remove EGFP+ Leydig cells. If we decided to pursue this model, we would need to 
optimize an enzymatic digestion protocol to separate tubular and interstitial components 
of mouse neonatal testis. This approach would likely reduce germ cell recovery. 
The last transgenic mouse model we examined is Uchl1-eGfp. It was first 
reported in 1988 that the neuronal protein UCHL1 was localized specifically to 
spermatogonia in neonatal mouse testes [148]. The results presented in this work 
confirm this observation. EGFP was expressed specifically in spermatogonia, but not in 
more developmentally advanced germ cells and somatic cells. Additionally, our findings 
suggest that the brightness of EGFP may be associated with fate of spermatogonia; 
UCHL1-EGFPdim spermatogonia may be a subset of undifferentiated spermatogonia. 
Our future work will optimize the FACS-based isolation of UCHL1-EGFP+ 
spermatogonia. These spermatogonia will be used in a variety of biochemical assays, 
such as metabolomics, proteomics, transcriptomics, and results will provide a clearer 
understanding of spermatogonial biology – particularly differentiation – and may result in 
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